Gene Environment Interactions in Parkinson's Disease

帕金森病的基因环境相互作用

基本信息

  • 批准号:
    7894952
  • 负责人:
  • 金额:
    $ 19.13万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-07-16 至 2012-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Our long term goal is to study the mechanism of neurodegeneration induced by environmental neurotoxicants. This proposal is submitted to investigate gene-environment interactions in the pathogenesis of Parkinson's disease mediated through the mitochondrial pathway. Mitochondrial dysfunction has been proposed as a major mechanism of neurodegeneration in PD for years, but direct evidence in humans was inadequate until the recent discoveries of mutations in PTEN-induced putative kinase 1 (PINK1), which encodes a mitochondrial kinase. Although PINK1 mutations are associated with autosomal recessive PD, interestingly, an increasing number of PD patients carrying single heterozygous mutations have been reported. These observations suggest that a heterozygous PINK1 mutation may act as a susceptibility factor that interplays with environmental insults. To determine the interactions between PINK1 mutations and environmental toxicants, we have created stable cell lines with inducible over-expression of various PINK1 mutants. Based on our preliminary results, we hypothesize that PINK1 mutations increase cell susceptibility to environmental toxicants such as paraquat (PQ) through a novel mechanism: mitochondrial fragmentation via the mitochondrial fission / fusion machinery. In the first specific aim, we will characterize neurotoxicity induced by PQ and MPP+ (two toxicants representing different mechanisms of toxicity) through the mitochondrial fission and fusion pathway in N27 cells with a PINK1 mutation (L347P) and empty vector control, as well as in N27 cells with PINK1 knockdown mediated by siRNA. We will assess cell viability, functional outcomes (ATP production, dopamine release and electron transport chain activity), as well as mitochondrial fragmentation (size/shape) and alterations in mitochondrial fission and fusion proteins. In specific aim 2, we will perform neuroprotective experiments against PQ and MPP+ toxicity in mutant PINK1 cells by targeting the mitochondrial fission and fusion pathway, through genetic manipulations and a small molecule. We will transfect cells with relevant constructs and use a chemical inhibitor to attenuate mitochondrial fragmentation. The neuroprotective effects of these two strategies against MPP+ and PQ toxicity will be determined using cell viability and functional assays as described in specific aim 1. PUBLIC HEALTH RELEVANCE This research may provide insights into the complexity of gene-environment interactions in the cause of cell death as seen in Parkinson's disease by unraveling a still unrecognized molecular pathway. Furthermore, this novel mechanism may offer an additional avenue to develop neuroprotective therapy for patients with Parkinson's disease.
描述(由申请人提供):我们的长期目标是研究环境神经毒物诱导的神经变性机制。本研究旨在探讨线粒体途径介导的帕金森病发病机制中基因与环境的相互作用。多年来,线粒体功能障碍一直被认为是帕金森病神经退行性变的主要机制,但在人类身上的直接证据不足,直到最近发现pten诱导的推定激酶1 (PINK1)突变,PINK1编码线粒体激酶。尽管PINK1突变与常染色体隐性PD相关,但有趣的是,越来越多的PD患者携带单杂合突变。这些观察结果表明,杂合子PINK1突变可能是与环境损害相互作用的易感因子。为了确定PINK1突变与环境毒物之间的相互作用,我们创建了稳定的细胞系,诱导各种PINK1突变体过表达。基于我们的初步结果,我们假设PINK1突变通过一种新机制增加了细胞对环境毒物如百草枯(PQ)的易感性:通过线粒体裂变/融合机制的线粒体断裂。在第一个特定目标中,我们将在PINK1突变(L347P)和空载体对照的N27细胞中,以及由siRNA介导的PINK1敲低的N27细胞中,通过线粒体裂变和融合途径,表征PQ和MPP+(两种代表不同毒性机制的毒物)诱导的神经毒性。我们将评估细胞活力,功能结果(ATP产生,多巴胺释放和电子传递链活性),以及线粒体碎片(大小/形状)和线粒体裂变和融合蛋白的变化。在特定目标2中,我们将通过遗传操作和小分子,针对线粒体裂变和融合途径,对突变PINK1细胞进行PQ和MPP+毒性的神经保护实验。我们将用相关构建体转染细胞,并使用化学抑制剂来减弱线粒体断裂。这两种策略对MPP+和PQ毒性的神经保护作用将通过细胞活力和功能测定来确定,如具体目标1所述。这项研究可能通过揭示一个尚未被识别的分子途径,为帕金森病中细胞死亡原因中基因-环境相互作用的复杂性提供见解。此外,这一新机制可能为开发帕金森病患者的神经保护疗法提供额外的途径。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

KIM TIEU其他文献

KIM TIEU的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('KIM TIEU', 18)}}的其他基金

Toxicant-induced neurotoxicity mediated by glia-neuron and gene-environment interactions in Parkinson's disease
帕金森病中神经胶质-神经元和基因-环境相互作用介导的毒物诱导的神经毒性
  • 批准号:
    10772772
  • 财政年份:
    2019
  • 资助金额:
    $ 19.13万
  • 项目类别:
Toxicant-induced neurotoxicity mediated by glia-neuron and gene-environment interactions in Parkinson's disease
帕金森病中神经胶质-神经元和基因-环境相互作用介导的毒物诱导的神经毒性
  • 批准号:
    10612382
  • 财政年份:
    2019
  • 资助金额:
    $ 19.13万
  • 项目类别:
Toxicant-induced neurotoxicity mediated by glia-neuron and gene-environment interactions in Parkinson's disease
帕金森病中神经胶质-神经元和基因-环境相互作用介导的毒物诱导的神经毒性
  • 批准号:
    10397027
  • 财政年份:
    2019
  • 资助金额:
    $ 19.13万
  • 项目类别:
Toxicant-induced synaptic dysfunction and neurotoxicity in Parkinson disease
帕金森病中毒物引起的突触功能障碍和神经毒性
  • 批准号:
    9356513
  • 财政年份:
    2016
  • 资助金额:
    $ 19.13万
  • 项目类别:
Toxicant-induced synaptic dysfunction and neurotoxicity in Parkinson disease
帕金森病中毒物引起的突触功能障碍和神经毒性
  • 批准号:
    8928180
  • 财政年份:
    2014
  • 资助金额:
    $ 19.13万
  • 项目类别:
Toxicant-induced synaptic dysfunction and neurotoxicity in Parkinson disease
帕金森病中毒物引起的突触功能障碍和神经毒性
  • 批准号:
    8696921
  • 财政年份:
    2014
  • 资助金额:
    $ 19.13万
  • 项目类别:
Gene Environment Interactions in Parkinson's Disease
帕金森病的基因环境相互作用
  • 批准号:
    8074236
  • 财政年份:
    2010
  • 资助金额:
    $ 19.13万
  • 项目类别:
Gene Environment Interactions in Parkinson's Disease
帕金森病的基因环境相互作用
  • 批准号:
    7706344
  • 财政年份:
    2009
  • 资助金额:
    $ 19.13万
  • 项目类别:
Environmental Toxicants and Neurodegeneration
环境毒物和神经退行性疾病
  • 批准号:
    7629108
  • 财政年份:
    2006
  • 资助金额:
    $ 19.13万
  • 项目类别:
Environmental Toxicants and Neurodegeneration
环境毒物和神经退行性疾病
  • 批准号:
    7848365
  • 财政年份:
    2006
  • 资助金额:
    $ 19.13万
  • 项目类别:

相似海外基金

A platform for rapidly generating live attenuated enterovirus vaccines
快速生成减毒肠道病毒活疫苗的平台
  • 批准号:
    24K02286
  • 财政年份:
    2024
  • 资助金额:
    $ 19.13万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
I-Corps: Translation potential of an efficient method to generate live-attenuated and replication-defective DNA viruses for vaccine development
I-Corps:一种有效方法的转化潜力,可生成用于疫苗开发的减毒活病毒和复制缺陷型 DNA 病毒
  • 批准号:
    2420924
  • 财政年份:
    2024
  • 资助金额:
    $ 19.13万
  • 项目类别:
    Standard Grant
Developing a robust native extracellular matrix to improve islet function with attenuated immunogenicity for transplantation
开发强大的天然细胞外基质,以改善胰岛功能,并减弱移植的免疫原性
  • 批准号:
    10596047
  • 财政年份:
    2023
  • 资助金额:
    $ 19.13万
  • 项目类别:
Live attenuated non-transmissible (LANT) Klebsiella pneumoniae vaccines
肺炎克雷伯氏菌减毒非传染性 (LANT) 活疫苗
  • 批准号:
    10742028
  • 财政年份:
    2023
  • 资助金额:
    $ 19.13万
  • 项目类别:
Protecting Pigs From Enzootic Pneumonia: Rational Design Of Safe Attenuated Vaccines.
保护猪免受地方性肺炎:安全减毒疫苗的合理设计。
  • 批准号:
    BB/X017540/1
  • 财政年份:
    2023
  • 资助金额:
    $ 19.13万
  • 项目类别:
    Research Grant
A “Goldilocks” live attenuated poultry vaccine for Infectious Coryza
用于传染性鼻炎的“Goldilocks”家禽减毒活疫苗
  • 批准号:
    LP210301365
  • 财政年份:
    2023
  • 资助金额:
    $ 19.13万
  • 项目类别:
    Linkage Projects
A novel live-attenuated Zika vaccine with a modified 5'UTR
一种带有改良 5UTR 的新型寨卡减毒活疫苗
  • 批准号:
    10730832
  • 财政年份:
    2023
  • 资助金额:
    $ 19.13万
  • 项目类别:
Combating melanoma with an attenuated bacterial therapeutic
用减毒细菌疗法对抗黑色素瘤
  • 批准号:
    10659841
  • 财政年份:
    2023
  • 资助金额:
    $ 19.13万
  • 项目类别:
Investigating Host and Viral Factors for Improved Design of Future Live Attenuated Vaccines for IBV
研究宿主和病毒因素以改进未来 IBV 减毒活疫苗的设计
  • 批准号:
    BB/V016067/1
  • 财政年份:
    2022
  • 资助金额:
    $ 19.13万
  • 项目类别:
    Research Grant
L2M NSERC-Bioengineering attenuated Sclerotinia sclerotiorum strains as bioherbicide for cereal production and lawn management
L2M NSERC-生物工程减毒核盘菌菌株作为谷物生产和草坪管理的生物除草剂
  • 批准号:
    576545-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 19.13万
  • 项目类别:
    Idea to Innovation
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了